Harlinde Peperstraete: From Circuit to Coagulation – Understanding Hemostasis in ECMO
Harlinde Peperstraete, Adjunct Kliniekhoofd at University Hospital Ghent, shared a post on LinkedIn about a recent article by she and her colleagues co-authored, published in Critical Care, adding:
“Very happy and proud to share our latest publication in Critical Care:
‘Extracorporeal life support and Modification Of Hemostasis:
the ELMOH trial:
hemostatic changes during the first 48 h of VV- and VAECMO: a prospective multicenter cohort study’
‘The hemostatic story starts before the circuit does.’
In this prospective multicenter cohort study, we explored hemostatic changes before and during the first 48 hours of VV- and VA-ECMO.
One of the key findings was that patients supported for circulatory failure and those supported for isolated respiratory failure already showed different hemostatic profiles at baseline.
VA-ECMO patients had lower platelet counts and a more hypocoagulable profile early on, while VV-ECMO patients remained relatively hypercoagulable during the first 48 hours.
These findings suggest that early coagulation abnormalities in ECMO patients reflect both the underlying clinical condition and the effects of extracorporeal support.
They support the need for individualized hemostatic monitoring and anticoagulation management.
A heartfelt thank you to my co-authors and collaborators for their dedication, insight, and teamwork:
Harlinde Peperstraete, Korneel Vandewiele, Katrien M. J. Devreese, Paul Massion, Michael Piagnerelli, Matthias Raes, Pieter Depuydt, and Eric Hoste.
This work would not have been possible without the ICU teams, study coordinators, and participating centers involved in patient inclusion, sampling, and data collection.
Because in ECMO, balancing bleeding and thrombosis is never routine, it is personal.”
Title: ExtracorporeaL life support and Modification Of Hemostasis: the ELMOH trial: hemostatic changes during the first 48 h of VV- and VA-ECMO: a prospective multicenter cohort study
Authors: Harlinde Peperstraete, Korneel Vandewiele, Katrien M. J. Devreese, Paul Massion, Michaël Piagnerelli, Matthias Raes, Pieter Depuydt and Eric Hoste
Stay updated on all scientific advances with Hemostasis Today.
-
May 14, 2026, 15:47Nathan Connell: A Valuable and Timely Discussion on The Future of Global Health Equity
-
May 14, 2026, 15:45Andreas Calatzis: Clot Retraction and Lysis in Viscoelastometry Explained
-
May 14, 2026, 15:43Muhammad Faiz: Types of Hemoglobin and Their Functions
-
May 14, 2026, 15:06Ana Pedrero Gil: Navigating Anemia Management in Patients With Stroke or Malignancy History
-
May 14, 2026, 15:00Snehal Gis: Gene Therapy Revolutionizing the Hemophilia Treatment Landscape
-
May 14, 2026, 14:43Sharon Bukola Afolabi: Why Standing Up Is a Bigger Workout for Your Heart Than You Think
-
May 14, 2026, 14:37Grigoris Gerotziafas: Join Our Workshop on Advancing Guideline Adoption in Cancer-Associated Thrombosis at ISTH 2026
-
May 14, 2026, 14:31Jonathan Douxfils: A Critical Review of NETosis Measurement Methods and the Need for Standardization
-
May 14, 2026, 14:21Mavis Agnes Kisakye: With Pride and Gratitude Haemophilia Foundation of Uganda Accepts the Project of the Year 2026 Award